Detection of SARS-CoV-2 BA.2.86 by lateral flow devices
Copyright © 2023. Published by Elsevier Ltd..
We evaluated the performance of 12 lateral flow devices by assessing their analytical sensitivity for SARS-CoV-2 variant BA.2.86. Kits from ACON, Orient Gene, Xiamen Biotime, Getein, and SureScreen detected variant BA.2.86 to sufficient sensitivity levels, comparable to those observed with previous Omicron variants. The stocks of lateral flow devices currently held by the UK government do not currently need changing for deployment for this variant.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:139 |
|---|---|
| Enthalten in: |
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 139(2024) vom: 20. Jan., Seite 168-170 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bown, Abbie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 15.01.2024 Date Revised 15.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ijid.2023.12.010 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366417592 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366417592 | ||
| 003 | DE-627 | ||
| 005 | 20240115232008.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijid.2023.12.010 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1260.xml |
| 035 | |a (DE-627)NLM366417592 | ||
| 035 | |a (NLM)38151115 | ||
| 035 | |a (PII)S1201-9712(23)00813-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bown, Abbie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Detection of SARS-CoV-2 BA.2.86 by lateral flow devices |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.01.2024 | ||
| 500 | |a Date Revised 15.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023. Published by Elsevier Ltd. | ||
| 520 | |a We evaluated the performance of 12 lateral flow devices by assessing their analytical sensitivity for SARS-CoV-2 variant BA.2.86. Kits from ACON, Orient Gene, Xiamen Biotime, Getein, and SureScreen detected variant BA.2.86 to sufficient sensitivity levels, comparable to those observed with previous Omicron variants. The stocks of lateral flow devices currently held by the UK government do not currently need changing for deployment for this variant | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a BA.2.86 | |
| 650 | 4 | |a LFD | |
| 650 | 4 | |a SARS-COV-2 | |
| 650 | 4 | |a lateral flow device | |
| 700 | 1 | |a Sweed, Angela |e verfasserin |4 aut | |
| 700 | 1 | |a Catton, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Nelthorpe-Cowne, Joshua |e verfasserin |4 aut | |
| 700 | 1 | |a Conti-Frith, Hermione |e verfasserin |4 aut | |
| 700 | 1 | |a Elderfield, Ruth |e verfasserin |4 aut | |
| 700 | 1 | |a Terrey, Jacob |e verfasserin |4 aut | |
| 700 | 1 | |a Abib, Hamsa |e verfasserin |4 aut | |
| 700 | 1 | |a Lui, Caleb |e verfasserin |4 aut | |
| 700 | 1 | |a Fisher, Ella |e verfasserin |4 aut | |
| 700 | 1 | |a Bewley, Kevin R |e verfasserin |4 aut | |
| 700 | 1 | |a Coombes, Naomi S |e verfasserin |4 aut | |
| 700 | 1 | |a Robinson, Donna |e verfasserin |4 aut | |
| 700 | 1 | |a Agrawal, Somya |e verfasserin |4 aut | |
| 700 | 1 | |a Hallis, Bassam |e verfasserin |4 aut | |
| 700 | 1 | |a Blandford, Edward |e verfasserin |4 aut | |
| 700 | 1 | |a Fowler, Tom |e verfasserin |4 aut | |
| 700 | 1 | |a Williamson, Deborah A |e verfasserin |4 aut | |
| 700 | 1 | |a Vipond, Richard |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases |d 1998 |g 139(2024) vom: 20. Jan., Seite 168-170 |w (DE-627)NLM094730857 |x 1878-3511 |7 nnns |
| 773 | 1 | 8 | |g volume:139 |g year:2024 |g day:20 |g month:01 |g pages:168-170 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ijid.2023.12.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 139 |j 2024 |b 20 |c 01 |h 168-170 | ||